| Name | Value |
|---|---|
| Revenues | 2,041.0K |
| Cost of Revenue | 1,436.0K |
| Gross Profit | 605.0K |
| Operating Expense | 4,334.0K |
| Operating I/L | -3,729.0K |
| Other Income/Expense | -447.0K |
| Interest Income | 445.0K |
| Pretax | -4,176.0K |
| Income Tax Expense | 445.0K |
| Net Income/Loss | -4,176.0K |
Avinger, Inc. is a medical device company specializing in image-guided and catheter-based systems for treating peripheral arterial disease (PAD). Its lumivascular platform integrates optical coherence tomography with interventional catheters, providing real-time intravascular imaging during PAD procedures. The company's products include Lightbox imaging consoles, Ocelot catheters for penetrating arterial blockages, Pantheris atherectomy device for plaque removal, and CTO-crossing catheters Wildcat and Kittycat 2. Avinger also develops IMAGE-BTK for below-the-knee PAD lesions. Its customers are interventional cardiologists, vascular surgeons, and interventional radiologists.